Loading...
Private Payer Coverage Policies for ApoE-e4 Genetic Testing
PURPOSE: ApoE-e4 has a well-established connection to late-onset Alzheimer’s disease (AD) and is available clinically. Yet, there have been no analyses of payer coverage policies for ApoE. Our objective is to analyze private payer coverage policies for ApoE genetic testing, examine the rationales, a...
Na minha lista:
| Udgivet i: | Genet Med |
|---|---|
| Main Authors: | , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
2021
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8035237/ https://ncbi.nlm.nih.gov/pubmed/33420342 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41436-020-01042-4 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|